Skip to main content

ETFMG Treatments Testing & Adv ETF(GERM-A)
NYSE Arca

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Overview

Name
Fund Family
Underlying Index
Inception Date
Exchange

Description

The ETFMG Treatments Testing and Advancements ETF seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the Prime Treatments, Testing and Advancements Index.

Investment Information

Managed Assets, $K
Shares Outstanding, K
Asset Class
60-Month Beta
Net Asset Value
Management Fee
Most Recent Dividend
Last Dividend Date
Dividend Yield
Has Options
20-Day Average Volume
52-Week RangeLow price15.67-High price21.70
YTD Return %
1-Year %Chg
3-Year %Chg
5-Year %Chg

More from The Globe